Ethereum has long been the backbone of decentralized finance (DeFi), driving innovation with smart contracts and permissionless trading. However, its limitations — high fees, congestion, and scalability issues — are hindering DeFi’s potential growth. Enter Injective. Founded in 2018 by Eric Chen and Albert Chon, Injective is a purpose-built blockchain designed to power high-performance DeFi applications like derivatives, spot trading, and structured products. With near-zero fees, lightning-fast finality, and interoperability across major chains, Injective aims to solve the very issues slowing Ethereum down. [1] This review explores how Injective functions, what makes it unique from other DeFi blockchains, and if it can truly scale decentralized finance for a global user base. Can Injective become the new engine driving DeFi’s next frontier? Let’s find out.